Earlier this week, we learned that two medications work better than single drugs in fighting HER-2 positive breast cancer. Now, researchers have found two chemotherapy drugs are better than one for colon cancer.

Prescription creams containing a compound known as i miquimod , such as Aldara , are known and approved to effectively treat some skin cancers, particularly basal cell carcinoma. New studies suggest this compound may be even more useful.

Blame it on the hormones. Male and female hormones are at the root of prostate cancer and breast cancer. They may also be the reason significantly more men than women develop liver cancer.

Years ago, cholesterol-lowering statin medications were thought to possibly cause cancer, bur large clinical trials disproved that therapy. Now, it seems these drugs may actually do just the opposite.

New research opens the door for new therapies to treat one of the worst sorts of cancer. Finding a genetic cause for esophageal cancer offers tremendous new opportunities.

Cancer researchers are doing more with existing drugs - looking for other applications of some and combining therapies. A combination cocktail seems to work well with HER2-positive breast cancer.

Zelboraf ( vemurafenib ) was hailed as a huge breakthrough in the treatment of metastatic melanoma, the most lethal form of skin cancer. Now, serious side effects are popping up.

Most cancer research eventually involves animals - usually mice. Some researchers are suggesting that these types of studies are not only weaker, but may not be achieving the right answers.

When you think of cancer, the image of a teenager probably doesn't come to mind. Yet the disease does indeed hit adolescents, though this group is largely ignored.

Back in 2005, Scottish researchers found surprisingly low rates of cancer among diabetes patients taking metformin , one of the most commonly used drugs for treating type 2 diabetes. Now, we may know why this happens.